PF-06700841: all 25 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• A Phase 2/3 Study of Brepocitinib in Adults With Lichen PlanopilarisRecruitingNCT07532603Phase 2/3
• A Study of Brepocitinib in Adults With Cutaneous SarcoidosisRecruitingNCT06978725Phase 2/3
• Dual JAK1/TYK2 Inhibitor for Cicatricial AlopeciaCompletedNCT05076006Phase 2Results posted
• Renal Impairment Study of PF-06700841CompletedNCT04260464Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis SuppurativaCompletedNCT04092452Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic ArthritisCompletedNCT03963401Phase 2Results posted
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisCompletedNCT03903822Phase 2Results posted
• Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In PsoriasisCompletedNCT03850483Phase 2Results posted
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)CompletedNCT03845517Phase 2Results posted
• A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo SubjectsCompletedNCT03715829Phase 2Results posted
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT03395184Phase 2Results posted
• Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia AreataCompletedNCT02974868Phase 2Results posted
• Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque PsoriasisCompletedNCT02969018Phase 2Results posted
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02958865Phase 2Results posted
• A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect InvestigationCompletedNCT02310750Phase 1Results posted
• A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant DermatomyositisCompletedNCT06433999Phase 2
• A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior UveitisCompletedNCT05523765Phase 2
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With DermatomyositisCompletedNCT05437263Phase 3
• Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release FormulationsCompletedNCT04580797Phase 1
• Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive SteroidsCompletedNCT04267250Phase 1
• A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy ParticipantsCompletedNCT04090047Phase 1
• Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy ParticipantsCompletedNCT03916250Phase 1
• Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different FormulationsCompletedNCT03765554Phase 1
• A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy VolunteersCompletedNCT03656952Phase 1
• Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy VolunteersCompletedNCT03236493Phase 1

← PF-06700841 overview